<DOC>
	<DOC>NCT00262236</DOC>
	<brief_summary>This is a study for people diagnosed with hypertension to compare the safety and effectiveness of aliskiren alone and in combination with atenolol. Each patient will be in the study for 12 weeks.</brief_summary>
	<brief_title>Efficacy and Safety of Aliskiren and Atenolol in Adults (&gt;18) With Mild to Moderate Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<criteria>1. Outpatients 18 years of age and older. 2. Patients with essential hypertension. Severe hypertension, Current diagnosis of heart failure, History or evidence of a secondary form of hypertension, Participation in any investigational drug study within one month of planned participation, Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Hypertension, Aliskiren, Atenolol, Blood Pressure</keyword>
</DOC>